Yahoo · Nov 20, 2026
Alcidion Group (ASX:ALC) Shares Fair Value Rises After MedTech Analysts Reassess Valuations
Alcidion Group’s narrative fair value has been reset sharply, moving from A$0.15 per share to A$1.48 per share as analysts update their price targets. That step change sits alongside broader MedTech commentary, where research houses are reassessing valuation frameworks, risk premiums and growth assumptions across the sector. As you read on, you will see how this new A$1.48 reference point fits into the evolving story around Alcidion Group and what to watch as the narrative continues to...

